| Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies S Yadav, SK Pandey, VK Singh, Y Goel, A Kumar, SM Singh PloS one 12 (5), e0176403, 2017 | 92 | 2017 |
| Antitumor and chemosensitizing action of 3-bromopyruvate: implication of deregulated metabolism S Yadav, SK Pandey, A Kumar, PK Kujur, RP Singh, SM Singh Chemico-biological interactions 270, 73-89, 2017 | 38 | 2017 |
| Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics SK Pandey, S Yadav, Y Goel, MK Temre, VK Singh, SM Singh Journal of theoretical biology 465, 117-125, 2019 | 29 | 2019 |
| Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor … S Yadav, PK Kujur, SK Pandey, Y Goel, BN Maurya, A Verma, A Kumar, ... Toxicology and Applied Pharmacology 339, 52-64, 2018 | 17 | 2018 |
| Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: implication of niche dependent … S Yadav, SK Pandey, Y Goel, PK Kujur, BN Maurya, A Verma, A Kumar, ... Biomedicine & Pharmacotherapy 99, 970-985, 2018 | 16 | 2018 |
| Glutor, a glucose transporter inhibitor, exerts antineoplastic action on tumor cells of thymic origin: Implication of modulated metabolism, survival, oxidative stress … MK Temre, S Yadav, Y Goel, SK Pandey, A Kumar, SM Singh Frontiers in Oncology 12, 925666, 2022 | 15 | 2022 |
| Diverse stakeholders of tumor metabolism: an appraisal of the emerging approach of multifaceted metabolic targeting by 3-bromopyruvate S Yadav, SK Pandey, Y Goel, MK Temre, SM Singh Frontiers in Pharmacology 10, 728, 2019 | 15 | 2019 |
| Cytotoxic action of acetate on tumor cells of thymic origin: role of MCT-1, pH homeostasis and altered cell survival regulation SK Pandey, S Yadav, Y Goel, SM Singh Biochimie 157, 1-9, 2019 | 12 | 2019 |
| Tracking acetate through a journey of living world: evolution as alternative cellular fuel with potential for application in cancer therapeutics SK Pandey, S Yadav, MK Temre, SM Singh Life sciences 215, 86-95, 2018 | 12 | 2018 |
| Tumor Decelerating and Chemo-Potentiating Action of Methyl Jasmonate on a T Cell Lymphoma In Vivo: Role of Altered Regulation of Metabolism, Cell Survival … Y Goel, S Yadav, SK Pandey, MK Temre, BN Maurya, A Verma, A Kumar, ... Frontiers in Oncology 11, 619351, 2021 | 10 | 2021 |
| Calcium/calmodulin-dependent protein kinase kinase 2 mediates pleiotropic effects of epidermal growth factor in cancer cells S Dai, E Venturini, S Yadav, X Lin, D Clapp, M Steckiewicz, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1869 (7), 119252, 2022 | 7 | 2022 |
| Methyl Jasmonate Cytotoxicity and Chemosensitization of T Cell Lymphoma In Vitro Is Facilitated by HK 2, HIF-1α, and Hsp70: Implication of Altered Regulation of … Y Goel, S Yadav, SK Pandey, MK Temre, VK Singh, A Kumar, SM Singh Frontiers in Pharmacology 12, 628329, 2021 | 4 | 2021 |
| Antimetabolic agent 3-bromopyruvate exerts myelopotentiating action in a murine host bearing a progressively growing ascitic thymoma S Yadav, SK Pandey, Y Goel, MK Temre, SM Singh Immunological Investigations 49 (4), 425-442, 2020 | 4 | 2020 |
| Molecular characterization of glutor-GLUT interaction and prediction of glutor’s drug-likeness: Implications for its utility as an antineoplastic agent MK Temre, B Devi, VK Singh, Y Goel, S Yadav, SK Pandey, R Kumar, ... Journal of Biomolecular Structure and Dynamics 41 (20), 11262-11273, 2023 | 2 | 2023 |
| Cytotoxic action of 3-bromopyruvate against tumor cells of thymoma origin: implication of diverse molecular mechanisms S Yadav, SK Pandey, A Kumar, PK Kujur, RP Singh, SM Singh CANCER MEDICINE 7, 48-49, 2018 | | 2018 |
